作者：
Atsushi,Isoda [1]
;
Kayoko,Murayama [2]
;
Shigeki,Ito [3]
;
Yoichi,Kohara [4]
;
Masaki,Iino [5]
;
Yuri,Miyazawa [6]
;
Morio,Matsumoto [6]
;
Hiroshi,Handa [7]
;
Yosuke,Imai [8]
;
Takuro,Ishiguro [8]
;
Wataru,Izumita [9]
;
Kiyoshi,Kitano [10]
;
Yukio,Hirabayashi [10]
;
Hideyuki,Nakazawa [11]
;
Fumihiro,Ishida [12]
;
Toru,Mitsumori [13]
;
Keita,Kirito [13]
;
Takaaki,Chou [8]
;
Hirokazu,Murakami [14]
;
Kanshinetsu Multiple Myeloma Study Group
作者单位：
Department of Hematology, National Hospital Organization Shibukawa Medical Center, 383 Shiroi, Shibukawa, Gunma, 377-0280, Japan. aisoda@sbmc.hosp.go.jp.
[1]
Department of Hematology, Gunma Cancer Center, Gunma, Japan.
[2]
Department of Medical Oncology, Iwate Medical University School of Medicine, Iwate, Japan.
[3]
Department of Hematology, Showa Inan General Hospital, Nagano, Japan.
[4]
Department of Medical Oncology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
[5]
Department of Hematology, National Hospital Organization Shibukawa Medical Center, 383 Shiroi, Shibukawa, Gunma, 377-0280, Japan.
[6]
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
[7]
Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
[8]
Department of Hematology, Iwate Prefecture Ofunato Hospital, Iwate, Japan.
[9]
Department of Hematology, National Hospital Organization Matsumoto Medical Center, Nagano, Japan.
[10]
Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan.
[11]
Department of Biomedical Laboratory Medicine, Shinshu University School of Medicine, Nagano, Japan.
[12]
Division of Hematology and Oncology, University of Yamanashi, Yamanashi, Japan.
[13]
Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan.
[14]
DOI
10.1007/s12185-018-2448-9
PMID
29594921
发布时间
2022-08-01
换一批
换一批
